
Rocket Lab booked the largest single contract in its corporate history, a multi-customer Neutron and Electron launch agreement that runs through 2029. Stacked on top of that came a $190 million hypersonic test deal covering 20 flights. Together they push the combined manifest past 70 missions and the total backlog above $2.2 billion. RKLB trades around $110 after a 30% run over the past 30 days and a 298% gain over the past year, and the next re-rate catalyst already has a date on the calendar.
That catalyst is Neutron's maiden flight, targeted for 2026. If it goes, Rocket Lab becomes the only near-term US medium-lift alternative to the dominant private space player, and the backlog stops being a promise on a press release and starts becoming revenue. Here is the breakdown.
The Contract That Actually Moved the Tape
The headline number is the new framework agreement covering both Neutron medium-lift and Electron small-lift missions through the end of 2029. Rocket Lab is treating the disclosure as the single largest commercial deal in its corporate history, and the structure matters more than the dollar value alone. Multi-customer framework agreements lock in slot capacity across multiple launch years, which is how SpaceX built its manifest into a $10 billion-plus pipeline. Rocket Lab is now running the same playbook at the next tier down.
The second piece, a $190 million contract for 20 hypersonic test flights, is the part most retail traders are underweighting. Hypersonic test launches are funded by defense customers who do not care about retail narrative cycles, do not care what the stock did this week, and pay on milestones. The Rocket Lab missions page shows how dense the cadence has become, with HASTE Electron variants already flying for defense customers ahead of Neutron's debut.
Add the two together and the math gets clean. Over 70 missions in the combined manifest. Over $2.2 billion in committed backlog. A revenue-recognition runway that extends past the Neutron qualification campaign into a production cadence where unit economics start to matter. The Rocket Lab IR page is the cleanest place to verify the backlog roll-forward each quarter.
And the stock has noticed. Up 30% over the past 30 days, up 298% over the past year. RKLB is no longer the speculative small-cap launcher it was in 2023. It is trading like a defense-and-space platform name with a known catalyst date.
Why Neutron Is the Re-Rate Trigger
Electron is a small-lift rocket. It carries roughly 300 kilograms to low Earth orbit and competes in a niche that pays well per kilogram but caps total revenue per mission. Neutron is the medium-lift vehicle, targeted at roughly 13,000 kilograms to LEO, reusable first stage, designed explicitly to take share in the constellation deployment market.
That is the market that matters. Constellation operators (government, commercial broadband, Earth observation, defense ISR) need medium-lift cadence and they need a second provider for redundancy. Right now there is effectively one dominant private provider in the US, and every constellation customer has a procurement officer whose performance review depends on not having a single point of failure. Rocket Lab is building the only credible near-term second source.
First flight is targeted for 2026. Rocket Lab has guided cautiously on the exact quarter, which is the right move because launcher first-flight slips are the norm rather than the exception. What matters for the stock is binary. If Neutron flies and reaches orbit, the backlog converts and the revenue ramp becomes a 2027-2028 story. If Neutron slips into late 2026 or 2027, the stock probably consolidates but the contracts stay on the books because customers signed multi-year frameworks for a reason.
This is where the comparison to pure pre-IPO exposure matters. If you want exposure to the dominant US space platform itself, the SpaceX pre-IPO guide walks through what is actually accessible to retail. RKLB is the listed second-source play that you can trade today, with a public order book and a transparent catalyst calendar.
The $190 Million Hypersonic Deal in Context
Defense launch contracts are different from commercial launch contracts in three ways that traders consistently underestimate.
First, the customer concentration risk is lower because the contracting authority (DoD, MDA, AFRL, individual service branches) is structurally stable across administrations. Second, margin profiles are higher because hypersonic test flights are not price-shopped against a published price sheet. Third, the cadence is set by the customer's test program, not by Rocket Lab's commercial pipeline, so it adds incremental flight count without cannibalizing commercial slots.
Twenty hypersonic flights at $190 million works out to roughly $9.5 million per mission, which is a healthy number for a small-lift variant like HASTE. Reuters and Bloomberg both maintain dedicated aerospace and defense coverage that tracks these awards as they hit, and the Bloomberg stocks dashboard is the easiest place to monitor how the defense launch tape is moving real names.
Source: Bloomberg
The other piece of context is that hypersonic test cadence in the US is structurally underbuilt. The Pentagon has consistently flagged hypersonic flight test capacity as a gating constraint on the broader hypersonic weapons program. Rocket Lab is one of a very small number of vendors that can fly the profile at all. That is the kind of structural advantage that holds up across market cycles.
What 30 Missions a Year Does to the Margin Profile
Rocket Lab has been a story stock. Once Neutron flies and the combined manifest enters production cadence, it becomes a margin story.
Here is the rough shape. At current Electron cadence (roughly 15-20 missions per year at peak), launch services run at modest gross margins because fixed costs spread thinly. At a combined cadence of 30 missions per year (Electron plus Neutron plus HASTE), the same fixed overhead spreads across roughly double the revenue base, and gross margin expansion compounds. Add the space systems business (satellite components, Photon spacecraft platforms) and the picture changes from "speculative launcher" to "vertically integrated space prime."
|
Metric
|
2024 actual
|
2026E (Neutron debut year)
|
2028E (cadence ramp)
|
|
Total launches
|
~14
|
~22 (incl. Neutron 1-2)
|
~30
|
|
Backlog
|
~$1.0B
|
~$2.2B+
|
TBD (refilled by new wins)
|
|
Vehicle mix
|
Electron only
|
Electron + Neutron debut
|
Electron + Neutron + HASTE
|
|
Margin direction
|
Story stage
|
Inflection
|
Operating leverage visible
|
The numbers in that table are rough analyst-consensus shapes, not company guidance. The actual quarterly cadence will live on the Rocket Lab quarterly results page and in the company's 8-K filings on SEC EDGAR, which is where the real news hits before it gets repackaged into headlines.
The honest version of the bear case sits next to that table. If Neutron slips a full year, the cadence math pushes right, the 2028 ramp becomes a 2029 ramp, and RKLB at $110 starts looking expensive on near-term revenue. That is the risk traders are pricing in when they ask why the stock pulls back 5-7% on no news.
How RKLB Fits Inside a Phemex Stock Sleeve
Most traders think of space exposure as one trade. It is not. There are three different shapes, and they pay differently in different macro regimes.
Listed launch platforms (RKLB). Public order book, daily liquidity, optionable, tradeable on catalyst timing. RKLB is the cleanest expression of "I want exposure to the medium-lift launch market as a public-market position I can size and exit."
Pre-IPO platform exposure. Access to the dominant private player is structurally harder and pays a different return profile. The Starlink and space economy guide lays out how the broader space economy is sized and where Starlink revenue sits inside it.
Listed peer space stocks. Smaller second-source names like SPCE trade on entirely different fundamentals (suborbital tourism rather than orbital launch), but they sit in the same retail-search space and move together on space-narrative news days. SPCE's recent trajectory is documented in detail, and the relative move between RKLB and SPCE is one of the cleanest reads on how the market is differentiating real backlog from narrative.
On a Phemex tokenized stock sleeve, RKLB is the highest-conviction listed launch exposure available. Around $110, with $2.2 billion in committed backlog and a 2026 catalyst on the books, the risk-reward is asymmetric in a way that pure macro-driven stocks rarely offer.
Frequently Asked Questions
Why is Rocket Lab's $2.2 billion backlog significant?
Backlog is committed future revenue. A $2.2 billion number against current annual revenue in the low hundreds of millions means there is roughly ten years of revenue already signed at current run-rate. The relevant question is conversion speed, and Neutron's first flight is what unlocks that conversion.
When is Neutron's first flight?
Targeted for 2026, with the exact quarter still subject to qualification testing. Launcher first-flight slips are common across the industry, so the prudent assumption is somewhere in 2026 with a non-trivial probability of slipping into 2027.
Is RKLB a competitor to the dominant private US launch provider?
At the Neutron tier, yes, in the medium-lift constellation deployment market. At the heavy-lift Starship tier, no. Rocket Lab is positioned as the credible second source for medium-lift, which is the segment with the highest commercial launch demand right now.
How does the $190 million hypersonic deal fit in?
It is incremental defense revenue at attractive per-mission economics, structurally insulated from commercial cycle risk, and it leverages Electron-class hardware that Rocket Lab already produces. It is the kind of contract that tells you the platform has government-customer credibility, which matters for the next round of defense awards.
Bottom Line
RKLB at around $110 is pricing in a successful 2026 Neutron debut, which means the asymmetric upside is in the cadence ramp from 2027 onward and the asymmetric downside is a Neutron slip into 2027. The $2.2 billion backlog and the $190 million hypersonic deal are the floor under the story. The catalyst calendar is binary in the best way. Watch the IR page for Neutron qualification milestones, watch SEC EDGAR for any 8-K contract disclosures between now and first flight, and size the position to survive a launcher delay without forcing an exit.
If Neutron flies and reaches orbit, this is the trade that re-rates a space-services company into a defense-and-space platform. If it slips, the contracts do not disappear, they just shift a quarter to the right.
Disclaimer: This article is for educational purposes only and does not constitute financial advice. Cryptocurrency and stock trading carries significant risk. Always do your own research and consult a qualified advisor.
